NCCN Guidelines Insights: Breast Cancer, Version 3.2018.

Authors :: Goetz MP
Gradishar WJ
Anderson BO
Abraham J
Aft R
Allison KH
Blair SL
Burstein HJ
Dang C
Elias AD
Farrar WB
Giordano SH
Goldstein LJ
Isakoff SJ
Lyons J
Marcom PK
Mayer IA
Moran MS
Mortimer J
O'Regan RM
Patel SA
Pierce LJ
Reed EC
Rugo HS
Sitapati A
Smith KL
Smith ML
Soliman H
Telli ML
Ward JH
Young JS
Shead DA
Kumar R
Source :: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2019 Feb; Vol. 17 (2), pp. 118-126.
Publication Year :: 2019
Abstract: These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.<br /> (Copyright © 2019 by the National Comprehensive Cancer Network.)